Your browser doesn't support javascript.
loading
Clarithromycin co-administration does not increase irinotecan (CPT-11) toxicity in colorectal cancer patients.
Makihara, Katsuya; Nakamura, Sayaka; Miyagi, Kazuyo; Ueno, Hiroyuki; Nakata, Izumi.
Affiliation
  • Makihara K; Department of Pharmacy, National Hospital Organization, Osaka National Hospital, Osaka, Japan. katsuya.ych@gmail.com.
  • Nakamura S; Department of Pharmacy, Yodogawa Christian Hospital, 1-7-50 Kunijima, Higashi Yodogawa-ku, Osaka, 533-0024, Japan. katsuya.ych@gmail.com.
  • Miyagi K; Department of Pharmacy, National Hospital Organization, Osaka National Hospital, Osaka, Japan.
  • Ueno H; Department of Pharmacy, National Hospital Organization, Osaka National Hospital, Osaka, Japan.
  • Nakata I; Department of Pharmacy, National Hospital Organization, Osaka National Hospital, Osaka, Japan.
Cancer Chemother Pharmacol ; 80(3): 527-533, 2017 Sep.
Article in En | MEDLINE | ID: mdl-28711984

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Camptothecin / Colorectal Neoplasms / Clarithromycin / Antineoplastic Agents, Phytogenic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2017 Document type: Article Affiliation country: Japan Country of publication: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Camptothecin / Colorectal Neoplasms / Clarithromycin / Antineoplastic Agents, Phytogenic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2017 Document type: Article Affiliation country: Japan Country of publication: Germany